Small and medium manufacturers with turnover of less than ₹250 crore may seek extension of the timeline by submitting a plan of upgradation within three months from now, the drug regulatory authority said in a notification issued on Tuesday.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/dYJo9qz
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment